BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1314 related articles for article (PubMed ID: 12265618)

  • 1. The state of the contraceptive art.
    Tyrer LB; Duarte J
    Plan Parent Rev; 1983; 3(2):5-7. PubMed ID: 12265618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Contraceptive development--the view from the U.S.A. in the mid 80s].
    Potts M; Siemens A; Burton N
    Contracept Fertil Sex (Paris); 1986 Mar; 14(3):247-51. PubMed ID: 12268061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weighing risks against benefits in contraceptive safety.
    Akhter HH
    Draper Fund Rep; 1983 Aug; (12):20-2. PubMed ID: 12338977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraceptive technologies: how much choice do we really have?
    Fishel J
    ZPG Report; 1997; 29(2):4-6. PubMed ID: 12293118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choosing a contraceptive. What's best for you?
    Anthony J
    Am Health; 1994 Apr; 13(3):68-71. PubMed ID: 12290558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Looking into the future.
    Potts M
    Plan Parent Rev; 1983; 3(2):3-5. PubMed ID: 12265636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IUDs, implants, Depo-Provera have "incredible return on investment".
    Contracept Technol Update; 1995 Jul; 16(7):81-4. PubMed ID: 12346506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal contraceptives merge old forms, new data.
    Contracept Technol Update; 1983 Jul; 4(7):73-5. PubMed ID: 12339358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
    Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal contraceptives: worldwide use remains low but methods have potential.
    Netw Res Triangle Park N C; 1986; 7(2):1, 5. PubMed ID: 12340618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Planned Parenthood continues prescribing birth control for teens.
    Contracept Technol Update; 1982 Jul; 3(9):110-2. PubMed ID: 12338301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contraceptive revolution revisited: new arrivals, same old rivals.
    Courtney H
    ZPG Report; 1993 Aug; 25(4):3. PubMed ID: 12286596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contraceptive technology from the administrator's perspective].
    Caram M
    Familia; 1984; 2(2):4-8. PubMed ID: 12178195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Not FDA-approved, but experts recommend Depo-Provera.
    Contracept Technol Update; 1992 Jan; 13(1):1-7. PubMed ID: 12343458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraception in the later reproductive years: a valid aspect of preventive health care.
    Speroff L; Sulak PJ
    Dialogues Contracept; 1995; 4(5):1-4. PubMed ID: 12288679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting steroid contraceptive technology.
    Grubb G
    Health Sex; 1991; 2(1):1-5, 7, 16. PubMed ID: 12343643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future barrier methods.
    Contracept Rep; 1997 Mar; 8(1):9-13. PubMed ID: 12290347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New labeling for contraceptives -- STDs.
    Contracept Rep; 1993 Nov; 4(5):14. PubMed ID: 12287402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility regulation technology: status and prospects.
    Segal SJ; Nordberg OS
    Popul Bull; 1977 Mar; 31(6):1-25. PubMed ID: 12335682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.